Literature DB >> 19324028

Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.

Chin-Hsiao Tseng1.   

Abstract

BACKGROUND: This study evaluated the lipid abnormalities associated with different stages of albuminuria in type 2 diabetic patients. METHODS AND
RESULTS: A total of 549 patients (245 men and 304 women) with mean age of 63.4 were studied. Normoalbuminuria (n=251), microalbuminuria (n=242) and macroalbuminuria (n=56) were defined as albumin-to-creatinine ratio of < 30, 30-299 and > or = 300 microg/mg, respectively. Lipid parameters included total cholesterol, triglyceride (TG), high- and low-density lipoprotein (LDL) cholesterol, apolipoproteins A1 and B (ApoB), and lipoprotein(a) [Lp(a)]. Results showed that ApoB differed significantly (p<0.05) between normoalbuminuria and microalbuminuria/macroalbuminuria and Ln[Lp(a)] differed between normoalbuminuria/microalbuminuria and macroalbuminuria. Ln(TG) increased progressively with increasing albuminuria. In multivariate logistic regression analyses, only ApoB showed significant odds ratio (95% confidence interval) for microalbuminuria: 1.013 (1.004-1.022); and both ln(TG) and ln[Lp(a)] were significant for macroalbuminuria [respective odds ratios: 1.995 (1.010-3.938) and 1.708 (1.200-2.430)].
CONCLUSIONS: A differential dyslipidemia is observed for microalbuminuria and macroalbuminuria. Apo(B) and Lp(a) increase at the stages of microalbuminuria and macroalbuminuria, respectively. However, TG increases significantly throughout the three stages of albuminuria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324028     DOI: 10.1016/j.clinbiochem.2009.03.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

1.  Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.

Authors:  Oemer-Necmi Goek; Anna Köttgen; Ron C Hoogeveen; Christie M Ballantyne; Josef Coresh; Brad C Astor
Journal:  Nephrol Dial Transplant       Date:  2012-01-28       Impact factor: 5.992

2.  Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications.

Authors:  Radhakrishnan Chandni; Kollengode Parameswaran Ramamoorthy
Journal:  World J Diabetes       Date:  2012-05-15

Review 3.  The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.

Authors:  Ai-Hua Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 4.  Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Authors:  Szu-chi Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

5.  Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index.

Authors:  Sílvia Juliane Piva; Etiane Tatsch; José Antonio Mainardi De Carvalho; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Maria Beatriz Moretto; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

6.  Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.

Authors:  Mohamed H Mahfouz; Adel M Assiri; Mohammed H Mukhtar
Journal:  Biomark Insights       Date:  2016-02-16

7.  Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy.

Authors:  Nai-Ching Chen; Chih-Hsin Chen; Tsu-Kung Lin; Shang-Der Chen; Meng-Han Tsai; Chiung-Chih Chang; Wan-Chen Tsai; Yao-Chung Chuang
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

8.  Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Ming-Fei Du; Wei-Hua Gao; Bo-Wen Fu; Qiong Ma; Yu Yan; Yue Yuan; Chao Chu; Chen Chen; Yue-Yuan Liao; Ke Gao; Ke-Ke Wang; Min Li; Yue Sun; Jia-Wen Hu; Xin Chen; Qiong Ma; Dan Wang; Xiao-Yu Zhang; Chun-Hua Li; Hao-Wei Zhou; Wan-Hong Lu; Zu-Yi Yuan; John Chang; Jian-Jun Mu
Journal:  Eur J Clin Nutr       Date:  2020-09-29       Impact factor: 4.016

9.  Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP).

Authors:  Subhasish Bose; Andrew S Bomback; Nehal N Mehta; Shu-Cheng Chen; Suying Li; Adam Whaley-Connell; Joseph Benjamin; Peter A McCullough
Journal:  BMC Nephrol       Date:  2012-09-07       Impact factor: 2.388

10.  Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  Anand Srivastava; Beverley Adams-Huet; Gloria L Vega; Robert D Toto
Journal:  J Investig Med       Date:  2016-07-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.